Can't say I agree with your justification. A stocks past performance, especially from years ago should not be used as a basis for a renewed run. This company should be and apparently is showing a bolstered PPS by its transition to reporting financials and subsequent uplisting. Also on it's increased year over year revenue. Also on it's strategy going forward including opening new locations, promoting their new internet based platform and the potential of entering into the exploding medical MJ space. Not to mention but every bit as important is their plans for M/A. These are legitimate reasons to believe this company's growth potential is NOT YET factored into the PPS. VERY UNDERVALUED
Market Data 
Markets 
AI
